|
 |
|
Medical Advisory Board
Raymond J. Fonseca, DMD
- D.M.D. University of Connecticut School Dental of Medicine
- Professor, Dept Oral and Maxillofacial Surgery, University of Pennsylvania, School
of Dental Medicine
- Recently Dean School of Dental Medicine, University Pennsylvania
- Past Professor, Dept Oral Medicine, Pathology and Surgery at University of Michigan,
School of Dentistry
Richard Goldfarb, M.D.
- Medical Dirctor, Bucks County Clinical Research, Inc.
- President/CEO, Preservation Sciences, Inc.
William J. Kelvie
- B.S. St John Fisher College, Rochester, NY
- Director Research Education, Office for Human Subject Protection,University of Rochester
Medical Center
- Director of Clinical Research Practices of the Clinical Research Institute at the
University of Rochester Medical Center
- Associate Director Clinical Research, Fisons Pharmaceutical
Seth I. Rosenberg, M.D.
- M.D. State University New York Upstate Medical Center
- Vice-President Florida Ear & Sinus Center, Sarasota, Fl.
- American Academy of Otolaryngology-Fellow head & Neck Surgery
- Clinical Assistant Professor Dept Otorhinolaryngology at University Pennsylvania
Medical Center
Herbert Silverstein, M.D.
- Founder & President of the Silverstein Institute
- Founder of the Florida Ear and Sinus Center
- Clinical Professor of Surgery, University of Pennsylvania Medical Center and University
of South Florida
James A. Stankiewicz,M.D.
- M.D. University of Chicago
- Professor and Vice-Chair Loyola University Dept Otolaryngology head & Neck Surgery
- Residency Program Director at Loyola for Otolaryngology
- Fellow of the American Academy of Otolaryngology since 1978
Jur T. Strobos, MD, JD.
- M.D. University of Chicago
- J.D. University of Pennsylvania
- Past FDA Director of Policy Research Staff, Office of Policy in the Commissioner’s
Office Of Counsel at Olsson, Frank and Weeda, P.C.
Michael Weintraub, M.D.
- M.D. University of Pennsylvania
- 20 years at University of Rochester, Director of Clinical Pharmacology
- head of FDA Office of Over the Counter Drug Branch 1991-1998
- Also headed FDA Office of Dermatologic, Dental, Analgesic, Anti-Inflammatory and
Ophthalmologic drugs
|
|